JP2022546763A5 - - Google Patents

Info

Publication number
JP2022546763A5
JP2022546763A5 JP2022514468A JP2022514468A JP2022546763A5 JP 2022546763 A5 JP2022546763 A5 JP 2022546763A5 JP 2022514468 A JP2022514468 A JP 2022514468A JP 2022514468 A JP2022514468 A JP 2022514468A JP 2022546763 A5 JP2022546763 A5 JP 2022546763A5
Authority
JP
Japan
Prior art keywords
antigen
carrier protein
sugar
protein conjugate
salmonella enterica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022514468A
Other languages
English (en)
Japanese (ja)
Other versions
JP7732974B2 (ja
JP2022546763A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2020/050763 external-priority patent/WO2021044436A2/en
Publication of JP2022546763A publication Critical patent/JP2022546763A/ja
Publication of JP2022546763A5 publication Critical patent/JP2022546763A5/ja
Priority to JP2024160658A priority Critical patent/JP2024178271A/ja
Application granted granted Critical
Publication of JP7732974B2 publication Critical patent/JP7732974B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022514468A 2019-09-03 2020-09-02 腸疾患に対する免疫原性組成物およびその調製のための方法 Active JP7732974B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024160658A JP2024178271A (ja) 2019-09-03 2024-09-18 腸疾患に対する免疫原性組成物およびその調製のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201921035435 2019-09-03
IN201921035435 2019-09-03
PCT/IN2020/050763 WO2021044436A2 (en) 2019-09-03 2020-09-02 Immunogenic compositions against enteric diseases and methods for its preparation thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024160658A Division JP2024178271A (ja) 2019-09-03 2024-09-18 腸疾患に対する免疫原性組成物およびその調製のための方法

Publications (3)

Publication Number Publication Date
JP2022546763A JP2022546763A (ja) 2022-11-08
JP2022546763A5 true JP2022546763A5 (https=) 2023-08-01
JP7732974B2 JP7732974B2 (ja) 2025-09-02

Family

ID=72659843

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022514468A Active JP7732974B2 (ja) 2019-09-03 2020-09-02 腸疾患に対する免疫原性組成物およびその調製のための方法
JP2024160658A Pending JP2024178271A (ja) 2019-09-03 2024-09-18 腸疾患に対する免疫原性組成物およびその調製のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024160658A Pending JP2024178271A (ja) 2019-09-03 2024-09-18 腸疾患に対する免疫原性組成物およびその調製のための方法

Country Status (23)

Country Link
US (2) US20230149524A1 (https=)
EP (2) EP4249061A3 (https=)
JP (2) JP7732974B2 (https=)
KR (2) KR20240155975A (https=)
CN (1) CN114728053A (https=)
AR (1) AR119884A1 (https=)
AU (1) AU2020343943A1 (https=)
BR (1) BR112022003892A2 (https=)
CA (1) CA3149972A1 (https=)
CO (1) CO2022003789A2 (https=)
CR (1) CR20220132A (https=)
EC (1) ECSP22031077A (https=)
GB (2) GB2603362B (https=)
GE (2) GEP20257808B (https=)
IL (1) IL291006B2 (https=)
JO (1) JOP20200214A1 (https=)
MA (1) MA56283A1 (https=)
MX (1) MX2022002693A (https=)
PE (1) PE20221442A1 (https=)
PH (1) PH12022550525A1 (https=)
PY (1) PY2051122A (https=)
WO (1) WO2021044436A2 (https=)
ZA (1) ZA202203368B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121569027A (zh) * 2023-07-21 2026-02-24 葛兰素史克生物有限公司 免疫原性组合物
WO2025217253A1 (en) * 2024-04-12 2025-10-16 Neogen Corporation Neutralizing compositions and related methods

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
AU1420897A (en) * 1996-12-18 1998-07-15 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Conjugate vaccine for (salmonella paratyphi) a
DE69941574D1 (de) 1998-08-19 2009-12-03 Baxter Healthcare Sa Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
PE20110072A1 (es) 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
GB0700135D0 (en) * 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Vaccine
FR2938265B1 (fr) 2008-11-12 2011-07-15 Univ Claude Bernard Lyon Procede pour le pilotage d'un traitement de depolymerisation par ultrasons d'un biopolymere hydrosoluble
CA2836153C (en) * 2009-12-17 2016-06-21 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
US9011871B2 (en) * 2011-11-07 2015-04-21 University Of Maryland, Baltimore Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
IN2012MU00206A (https=) * 2012-01-20 2013-08-09
MX354103B (es) 2012-01-30 2018-02-13 Serum Inst India Ltd Composicion inmunogenica.
CN102935226B (zh) * 2012-11-16 2014-01-22 罗益（无锡）生物制药有限公司 伤寒甲型副伤寒结合疫苗及其制备方法
KR102447303B1 (ko) * 2013-08-24 2022-09-23 브하라트 바이오테크 인터내셔날 리미티드 박테리아성 백신 및 그의 제조방법
CN104383532A (zh) * 2014-12-02 2015-03-04 云南沃森生物技术股份有限公司 一种用乙肝表面抗原为载体蛋白的细菌多糖蛋白结合物疫苗及其制备方法
CN104587461A (zh) * 2015-01-05 2015-05-06 云南沃森生物技术股份有限公司 伤寒、甲型乙型副伤寒多糖蛋白结合型多价联合疫苗
WO2017006349A1 (en) * 2015-07-04 2017-01-12 Bharat Biotech International Limited Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides
US20190134177A1 (en) * 2016-04-25 2019-05-09 National Institute Of Immunology Conjugate for vaccination against typhoid comprising chemical conjugate of vi polysaccharide and flagellin, a process for producing the same and a composition comprising the conjugate
MY191163A (en) 2016-08-26 2022-06-03 The Centers For Disease Control And Prevention Cdc Multivalent vaccine composition
US11739356B2 (en) * 2017-05-05 2023-08-29 Serum Institute Of India Private Limited Method for removal of impurities from bacterial capsular polysaccharide based preparations
CN111032078A (zh) 2017-07-18 2020-04-17 血清研究所印度私人有限公司 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法
EA202190778A1 (ru) 2018-10-12 2021-08-05 Серум Инститьют Оф Индия Прайват Лтд Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения
MX2021005500A (es) * 2018-11-10 2021-09-08 Bharat Biotech Int Ltd Composiciones inmunogenicas de glicoconjugados multivalentes.

Similar Documents

Publication Publication Date Title
US12016914B2 (en) Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
AU2011226160B2 (en) Conjugation process of bacterial polysaccharides to carrier proteins
CA2828787C (en) Conjugation of anitigen to carrier protein using triacetoxyborohydride
JP2020514326A (ja) 肺炎連鎖球菌多糖−タンパク質コンジュゲートの免疫原性の増強
US20250134980A1 (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof
JP2022546763A5 (https=)
CA3123414C (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
AU2012101554B4 (en) Conjugation process of bacterial polysaccharides to carrier proteins
BR122024027321A2 (pt) Composições imunogênicas de vacina
OA20613A (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof.
EA048341B1 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ КОНЪЮГАТЫ ПОЛИСАХАРИДА ИЗ Streptococcus pneumoniae И БЕЛКА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ